| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |